Chinese pharmaceutical tech firm XtalPi nets $319m in Series C round

XtalPi integrates quantum physics and AI to create computational drug discovery and development applications that accurately predict important drug properties of small molecules. Source: XtalPi

Eudora Wang

28 September, 2020

AI ID4 platform Morningside Venture Capital PICC Capital SoftBank Vision Fund 2 XtalPi

Printed by Unregistered user on Sat, 12 Jul 2025 05:14:16 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

Chinese pharmaceutical tech firm XtalPi nets $319m in Series C round

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

Bajaj Finserv forays into healthtech with fully-owned subsidiary

Chinese healthtech firm Kyee raises $64m in Series D round led by Tencent

Read more from Greater China

Shanghai to consider policy responses to stablecoins, cryptocurrencies

China’s Chery, BYD may have to repay subsidies after audit finds improper claims

Chinese pharmaceutical tech firm XtalPi nets $319m in Series C round

Register now to enjoy 3 free articles per month, or log in to continue reading.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

You may also like

Bajaj Finserv forays into healthtech with fully-owned subsidiary

Chinese healthtech firm Kyee raises $64m in Series D round led by Tencent

Read more from Greater China

Shanghai to consider policy responses to stablecoins, cryptocurrencies

China’s Chery, BYD may have to repay subsidies after audit finds improper claims

Register now to enjoy 3 free articles per month,
or log in to continue reading.